YEAR
- 2004.09.23 Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. Minami T, Horiuchi K, Miura M, Abid MR, Takabe W, Noguchi N, Kohro T, Ge X, Aburatani H, Hamakubo T, Kodama T, Aird WC.J. Biol. Chem. 2004 Nov 26;279(48):50537-54. doi: 10.1074/jbc.M406454200
- 2004.12.29 The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT.J. Atheroscler. Thromb. 2004;11(4):200-8. doi: 10.5551/jat.11.200
- 2004.04.19 The very low density lipoprotein (VLDL) receptor--a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues. Takahashi S, Sakai J, Fujino T, Miyamori I, Yamamoto TT.Mol. Cell. Biochem. 2003 Jun;248(1-2):121-7. doi: 10.1023/a:1024184201941
- 2004.06.01 The first crystal structure of the novel class of fructose-1,6-bisphosphatase present in thermophilic archaea Nishimasu H, Fushinobu S, Shoun H, Wakagi TStructure. 2004 Jun;12(6):949-59. doi: 10.1016/j.str.2004.03.026.
- 2004.04.09 The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1. Urushibara M, Takayanagi H, Koga T, Kim S, Isobe M, Morishita Y, Nakagawa T, Löeffler M, Kodama T, Kurosawa H, Taniguchi T.Arthritis Rheum. 2004 Mar;50(3):794-804. doi: 10.1002/art.20206
- 2004.08.27 Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, Wendling O, Tanaka T, Kodama T, Thomas W, Auwerx J, Schoonjans K.Mol. Cell. 2004 Aug 27;15(4):499-509. doi: 10.1016/j.molcel.2004.07.009
- 2004.01.22 STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression. Joo A, Aburatani H, Morii E, Iba H, Yoshimura A.Oncogene. 2004 Jan 22;23(3):726-34. doi: 10.1038/sj.onc.1207174
- 2004.07.21 Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, Nishino I, Ezaki O.J. Biol. Chem. 2004 Sep 24;279(39):41114-23. doi: 10.1074/jbc.M400674200
CLOSE